Search Within

GDMT, Medicine

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (239)
  2. Meeting Abstract (141)
  3. Editorial (3)
  4. Book Section (1)
  5. Research Letter (1)
  6. Review (1)
Groups
  1. Department of Medicine (386)
  2. Epidemiology and Biostatistics (386)
  3. Gynecology Disease Management Team (386)
  4. Solid Tumor Oncology Division (382)
  5. Gynecologic Medicine Service (366)
  6. Biostatistics Service (314)

More Groups

People
  1. Alexia Iasonos (186)
  2. Carol Aghajanian (163)
  3. Qin Zhou (143)
  4. Nadeem Abu-Rustum (87)
  5. Dennis Chi (85)
  6. Martee Hensley (83)

More People

Years
  1. 2025 (10)
  2. 2024 (28)
  3. 2023 (34)
  4. 2022 (44)
  5. 2021 (27)
  6. 2020 (33)

More Years

Publications
  1. Gynecologic Oncology (92)
  2. Journal of Clinical Oncology (90)
  3. International Journal of Gynecological Cancer (37)
  4. Clinical Cancer Research (14)
  5. Cancer (12)
  6. Cancer Research (11)

More Publications

Publishers
  1. Elsevier Inc. (102)
  2. American Society of Clinical Oncology (100)
  3. Lippincott Williams & Wilkins (39)
  4. American Association for Cancer Research (36)
  5. Nature Publishing Group (16)
  6. Wiley Blackwell (16)

More Publishers

Results (386)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TERT promoter mutations and gene amplification in endometrial cancer
    Journal Article

    Praiss, A. M.; Marra, A.; Zhou, Q.; Rios-Doria, E.; Momeni-Boroujeni, A.; Iasonos, A.; Selenica, P.; Brown, D. N.; Aghajanian, C.; Abu-Rustum, N. R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer
    Journal Article

    Zammarrelli, W. A. 3rd; Ma, W.; Espino, K.; Gordhandas, S.; Yeoshoua, E.; Ehmann, S.; Zhou, Q.; Iasonos, A.; Abu-Rustum, N. R.; Aghajanian, C.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Movva, S.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, Ciara M.; Keohan, M. L.; Meyers, P. A.; Cohen, S. M.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Ancestry-adjusted genomic analysis to identify known and novel associations with single and multiple cancer phenotypes
    Meeting Abstract

    Joseph, V.; Ravichandran, V.; Ostrovnaya, I.; Liu, Y. L.; Tkachuk, K.; Khurram, A.; Kemel, Y.; Mandelker, D.; Bandlamudi, C.; Walsh, M. F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Pathogenic germline variants in patients with endometrial cancer across diverse ancestries
    Meeting Abstract

    Liu, Y. L.; Gordhandas, S.; Arora, K.; Maio, A.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E. E.; Zhou, Q.; Iasonos, A.; Selenica, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Germline variants in non- BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival
    Meeting Abstract

    Kahn, R. M.; Selenica, P.; Boerner, T.; Xiao, Y.; Sia, T.; Sheehan, M.; Zhou, Q.; Iasonos, A.; Grisham, R. N.; O'Cearbhaill, R. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Liu, D.; Makker, V.; Buonocore, D. J.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Johnson, A.; Offin, M.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Noninvasive assessment of human epidermal growth factor receptor 2 (HER2) in esophagogastric cancer using (89)Zr-trastuzumab PET: A pilot study
    Journal Article

    Lumish, M. A.; Maron, S. B.; Paroder, V.; Chou, J. F.; Capanu, M.; Philemond, S.; O'Donoghue, J. A.; Schoder, H.; Lewis, J. S.; Lyashchenko, S. K.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Leave it in the past - Primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study
    Journal Article

    Sia, T. Y.; Manning-Geist, B. L.; Ehmann, S.; Lavery, J. A.; Luardo, C.; Praiss, A.; Iasonos, A.; Sonoda, Y.; Grisham, R. N.; Liu, Y. L.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Chemotherapy response in low-grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies
    Journal Article

    Manning-Geist, B. L.; Kahn, R. M.; Nemirovsky, D.; Girshman, J.; Laibangyang, A.; Gordhandas, S.; Iasonos, A.; Chui, M. H.; Long Roche, K.; Zivanovic, O.; more...
    Cancer (2023)

    Fulltext@MSK | Save